A phase 2 consortium (P2C) trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP) for advanced adenocarcinoma of the pancreas
- Steven Attia
- , Jill Kolesar
- , Michelle R. Mahoney
- , Henry C. Pitot
- , Daniel Laheru
- , James Heun
- , Wei Huang
- , Jens Eickhoff
- , Charles Erlichman
- , Kyle D. Holen
Producción científica: Article › revisión exhaustiva
78
Citas
(Scopus)